Immunovant, Inc.
IMVT • NASDAQ
Immunovant, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Venker, with a market cap of $5.2B.
Market Cap$5.2B
Employees207.0
CEOEric Venker
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 28, 2026 · in a monthQ4 2026
Financials
IMV
Immunovant, Inc. FAQ
Common questions about Immunovant, Inc.
Immunovant, Inc. is scheduled to report earnings for Q4 2026 on May 28, 2026.
Immunovant, Inc. has approximately 207 employees.